Table 3 Patients administered hemostatic therapies and allogeneic blood component transfusions in conjunction with prothrombin complex concentrate
| Â | Number of patients (%) | |||
|---|---|---|---|---|
| Â | Reversal group (n = 12) | Bleeding group (n = 38) | ||
Hemostatic therapies | Â | Â | Â | Â |
Vitamin K | 7 (58) | 5 (13) | ||
Desmopressin | 0 (0) | 7 (18) | ||
Fibrinogen concentrate | 0 (0) | 4 (11) | ||
Allogeneic blood components | Within 6 h before PCC | Within 6 h after PCC | Within 6 h before PCC | Within 6 h after PCC |
Red blood cells | 1 (8) | 1 (8) | 21 (55) | 16 (42) |
Fresh frozen plasma | 0 (0) | 2 (17) | 12 (32) | 11 (29) |
Platelets | 1 (8) | 1 (8) | 7 (18) | 3 (8) |